Is the risk of ibuprofen or other non‐steroidal anti‐inflammatory drugs increased in COVID‐19?
| Field | Value | Language |
| dc.contributor.author | Vosu, Joel | en |
| dc.contributor.author | Britton, Philip | en |
| dc.contributor.author | Howard-Jones, Annaleise | en |
| dc.contributor.author | Isaacs, David | en |
| dc.contributor.author | Kesson, Alison | en |
| dc.contributor.author | Khatami, Ameneh | en |
| dc.contributor.author | Marais, Ben | en |
| dc.contributor.author | Nayda, Claire | en |
| dc.contributor.author | Outhred, Alexander | en |
| dc.date.accessioned | 2020-09-14 | |
| dc.date.available | 2020-09-14 | |
| dc.date.issued | 2020 | en |
| dc.identifier.uri | https://hdl.handle.net/2123/23307 | |
| dc.language.iso | en | en |
| dc.rights | Other | |
| dc.subject | COVID-19 | en |
| dc.subject | Coronavirus | en |
| dc.title | Is the risk of ibuprofen or other non‐steroidal anti‐inflammatory drugs increased in COVID‐19? | en |
| dc.type | Article, Letter | en |
| dc.identifier.doi | 10.1111/jpc.15159 | |
| usyd.faculty | Faculty of Medicine and Health, Sydney Medical School | en |
Associated file/s
There are no files associated with this item.
Associated collections